Exhibit 99.2

ASML — Summary U.S. GAAP Consolidated Statements of Operations^1,4

	Three months ended,
(in thousands EUR, except per share data)	Apr 1, 2007			Mar 30, 2008
Net system sales		847,376			819,986
Net service and field option sales		101,295			99,222
Total net sales		948,671			919,208
Cost of sales		556,853			545,583
Gross profit on sales		391,818			373,625
Research and development costs, net of credits		116,442			128,259
Amortization of in process R&D		23,148			—
Selling, general and administrative costs		56,330			57,328
Income from operations		195,898			188,038
Interest income		10,260			4,203
Income from operations before income taxes		206,158			192,241
Provision for income taxes		(53,483	)		(47,118	)
Net income		152,675			145,123
Basic net income per ordinary share		0.32			0.34
Diluted net income per ordinary share		0.31	2,3		0.33	3
Number of ordinary shares used in computing per share amounts (in thousands):
Basic		473,573			431,600
Diluted		502,613	2,3		434,959	3

ASML — Ratios and Other Data^1,4

	Three months ended,
	Apr 1, 2007		Mar 30, 2008
Gross profit as a % of net sales		41.3		40.6
Income from operations as a % of net sales		20.6		20.5
Net income as a % of net sales		16.1		15.8
Shareholders’ equity as a % of total assets		53.3		44.5
Income taxes as a % of income before income taxes		25.9		24.5
Sales of systems total (in units)		77		50
ASP of systems sales (EUR million)		11.0		16.4
Value of backlog systems total (EUR million)		2,163		1,167
Backlog systems total (in units)		148		65
ASP of backlog systems (EUR million)		14.6		18.0
Value of bookings systems total (EUR million)		911		312
Net bookings total (in units)		62		26
ASP of bookings systems (EUR million)		14.7		12.0
Number of employees		5,975		6,765

ASML — Summary U.S. GAAP Consolidated Balance Sheets^1,4

(in thousands EUR)	Dec 31, 2007		Mar 30, 2008
ASSETS
Cash and cash equivalents		1,271,636		1,397,144
Accounts receivable, net		637,975		741,515
Inventories, net		1,102,210		1,152,010
Deferred tax assets short-term		73,019		71,031
Other current assets		234,529		267,586
Total current assets		3,319,369		3,629,286
Deferred tax assets long-term		141,032		135,836
Other assets		59,991		85,700
Goodwill		128,271		119,717
Other intangible assets, net		38,195		32,507
Property, plant and equipment, net		380,894		401,359
Total assets		4,067,752		4,404,405
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,321,442		1,562,261
Deferred tax and other liabilities		245,415		261,507
Other deferred liabilities		7,936		7,170
Other long-term debt		602,016		615,313
Total liabilities		2,176,809		2,446,251
Shareholders’ equity		1,890,943		1,958,154
Total liabilities and shareholders’ equity		4,067,752		4,404,405

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows^1,4

	Three months ended,
(in thousands EUR)	Apr 1, 2007			Mar 30, 2008
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		152,675			145,123
Depreciation and amortization		53,362			30,576
Change in tax assets and liabilities		18,742			21,797
Change in assets and liabilities		(53,011	)		65,186
Net cash provided by operating activities		171,768			262,682
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment		(35,789	)		(55,032	)
Proceeds from sale of property, plant and equipment		4,306			1,103
Acquisition of subsidiary (net of cash acquired)		(188,011	)		—
Net cash used in investing activities		(219,494	)		(53,929	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Purchase of shares in conjunction with conversion rights of bond holders and stock options		(156,253	)		(87,603	)
Net proceeds from issuance of shares and stock options		12,815			6,542
Excess tax benefits from stock options		627			2
Redemption and/or repayment of debt		(234	)		—
Net cash used in financing activities		(143,045	)		(81,059	)
Net cash flows		(190,771	)		127,694
Effect of changes in exchange rates on cash		(1,874	)		(2,186	)
Net increase (decrease) in cash & cash equivalents		(192,645	)		125,508

ASML — Quarterly Summary U.S. GAAP Consolidated Statements of Operations^1,4

	Three months ended,
	Apr 1,			Jul 1,			Sep 30,			Dec 31,			Mar 30,
(in millions EUR)	2007			2007			2007			2007			2008
Net system sales		847.4			825.8			843.2			834.8			820.0
Net service and field option sales		101.3			104.4			91.2			120.1			99.2
Total net sales		948.7			930.2			934.4			954.9			919.2
Cost of sales		556.9			546.9			549.4			565.3			545.6
Gross profit on sales		391.8			383.3			385.0			389.6			373.6
Research and development costs, net of credits		116.5			120.3			120.1			129.3			128.3
Amortization of in process R&D		23.1			—			—			—			—
Selling, general and administrative costs		56.3			56.4			56.0			56.9			57.3
Income from operations		195.9			206.6			208.9			203.4			188.0
Interest income		10.3			8.1			9.5			5.5			4.2
Income from operations before income taxes		206.2			214.7			218.4			208.9			192.2
Provision for income taxes		(53.5	)		(55.2	)		(52.1	)		(8.1	)		(47.1	)
Net income		152.7			159.5			166.3			200.8			145.1

ASML — Quarterly Summary Ratios and other data^1,4

	Three months ended,
	Apr 1,		Jul 1,		Sep 30,		Dec 31,		Mar 30,
	2007		2007		2007		2007		2008
Gross profit as a % of net sales		41.3		41.2		41.2		40.8		40.6
Income from operations as a % of net sales		20.6		22.2		22.4		21.3		20.5
Net income as a % of net sales		16.1		17.1		17.8		21.0		15.8
Shareholders’ equity as a % of total assets		53.3		47.3		35.7		46.5		44.5
Income taxes as a % of income before income taxes		25.9		25.7		23.9		3.9		24.5
Sales of systems total (in units)		77		69		59		55		50
ASP of system sales (EUR million)		11.0		12.0		14.3		15.2		16.4
Value of backlog systems total (EUR million)		2,163		1,745		1,769		1,697		1,167
Backlog systems total (in units)		148		109		90		89		65
ASP of backlog systems (EUR million)		14.6		16.0		19.7		19.1		18.0
Value of booking systems total (EUR million)		911		399		857		803		312
Net bookings total (in units)		62		30		40		54		26
ASP of bookings systems (EUR million)		14.7		13.3		21.4		14.9		12.0
Number of employees		5,975		6,213		6,403		6,582		6,765

ASML — Summary U.S. GAAP Consolidated Balance Sheets^1,4

	Apr 1,		Jul 1,		Sep 30,		Dec 31,		Mar 30,
(in millions EUR)	2007		2007		2007		2007		2008
ASSETS
Cash and cash equivalents		1,463.2		2,299.2		2,445.2		1,271.6		1,397.1
Accounts receivable, net		648.6		567.8		611.7		638.0		741.5
Inventories, net		906.7		972.9		1,021.2		1,102.2		1,152.0
Deferred tax assets short-term		140.9		131.8		131.3		73.0		71.1
Other current assets		169.6		183.7		214.2		234.6		267.6
Total current assets		3,329.0		4,155.4		4,423.6		3,319.4		3,629.3
Deferred tax assets long-term		179.0		203.0		143.5		141.0		135.8
Other assets		37.4		43.0		39.9		60.0		85.7
Goodwill		141.7		140.2		133.4		128.3		119.7
Other intangible assets, net		52.9		49.7		44.2		38.2		32.5
Property, plant and equipment, net		288.5		313.5		343.3		380.9		401.4
Total assets		4,028.5		4,904.8		5,127.9		4,067.8		4,404.4
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities		1,230.0		1,331.2		2,391.5		1,321.4		1,562.3
Deferred tax and other liabilities		260.0		273.6		248.3		245.4		261.5
Other deferred liabilities		9.5		8.2		8.2		8.0		7.1
Convertible subordinated debt		380.0		380.0		44.5		—		—
Other long-term debt		1.3		593.8		604.0		602.0		615.3
Total liabilities		1,880.8		2,586.8		3,296.5		2,176.8		2,446.2
Shareholders’ equity		2,147.7		2,318.0		1,831.4		1,891.0		1,958.2
Total liabilities and shareholders’ equity		4,028.5		4,904.8		5,127.9		4,067.8		4,404.4

ASML — Summary U.S. GAAP Consolidated Statements of Cash Flows^1,4

	Three months ended,
	Apr 1,			Jul 1,			Sep 30,			Dec 31,			Mar 30,
(in millions EUR)	2007			2007			2007			2007			2008
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income		152.7			159.5			166.3			200.8			145.1
Depreciation and amortization		53.4			24.1			28.0			29.8			30.6
Change in tax assets and liabilities		18.7			10.8			(5.3	)		(0.6	)		21.8
Change in assets and liabilities		(53.0	)		63.0			(20.0	)		(157.9	)		65.2
Net cash provided by operating activities		171.8			257.4			169.0			72.1			262.7
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment		(35.8	)		(39.7	)		(49.7	)		(54.0	)		(55.0	)
Proceeds from sale of property, plant and equipment		4.3			9.9			1.7			3.3			1.1
Acquisition of subsidiary (net of cash acquired)		(188.0	)		—			—			—			—
Net cash used in investing activities		(219.5	)		(29.8	)		(48.0	)		(50.7	)		(53.9	)
CASH FLOWS FROM FINANCING ACTIVITIES:
Capital repayment		—			—			—			(1,011.9	)		—
Purchase of shares in conjunction with conversion rights of bond holders and stock options		(156.3	)		—			—			(203.6	)		(87.6	)
Net proceeds from issuance of shares and stock options		12.8			15.0			29.1			30.7			6.5
Net proceeds from issuance of bonds		—			593.8			—			—			—
Excess tax benefits from stock options		0.6			0.1			0.2			0.2			—
Redemption and/or repayment of debt		(0.2	)		(0.1	)		(1.5	)		(7.8	)		—
Net cash provided by (used in) financing activities		(143.1	)		608.8			27.8			(1,192.4	)		(81.1	)
Net cash flows		(190.8	)		836.4			148.8			(1,171.0	)		127.7
Effect of changes in exchange rates on cash		(1.9	)		(0.4	)		(2.8	)		(2.6	)		(2.2	)
Net increase (decrease) in cash & cash equivalents		(192.7	)		836.0			146.0			(1,173.6	)		125.5

ASML — Notes to the Summary U.S. GAAP Consolidated Financial Statements

Basis of Presentation

ASML follows accounting principles generally accepted in the United States of America (“U.S. GAAP”). Further disclosures, as required under U.S. GAAP in annual reports, are not included in the summary consolidated financial statements. Unless stated otherwise, the accompanying consolidated financial statements are stated in thousands of euros (‘EUR’).

Principles of consolidation

The consolidated financial statements include the accounts of ASML Holding N.V. and all of its majority-owned subsidiaries. Subsidiaries are all entities over which ASML has the power to govern the financial and operating policies generally accompanying a shareholding of more than one half of the voting rights. All intercompany profits, balances and transactions have been eliminated in the consolidation.

Use of estimates

The preparation of ASML’s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities on the balance sheet dates and the reported amounts of revenue and expense during the reported periods. Actual results could differ from those estimates.

Recognition of revenues

ASML recognizes revenue when all four revenue recognition criteria are met: persuasive evidence of an arrangement exists; delivery has occurred or services have been rendered; seller’s price to the buyer is fixed or determinable; and collectibility is reasonably assured. At ASML, this policy generally results in revenue recognition from the sale of a system upon shipment. The revenue from the installation of a system is generally recognized upon completion of that installation at the customer site. Each system undergoes, prior to shipment, a “Factory Acceptance Test” in ASML’s clean room facilities, effectively replicating the operating conditions that will be present on the customer’s site, in order to verify whether the system will meet its standard specifications and any additional technical and performance criteria agreed with the customer. A system is shipped, and revenue recognized, only after all specifications are met and customer sign-off is received or waived. Although each system’s performance is re-tested upon installation at the customer’s site, ASML has never failed to successfully complete installation of a system at a customer’s premises.

For arrangements containing multiple elements, the revenue relating to the undelivered elements is deferred at estimated fair value until delivery of these elements. Revenue from installation services and service contracts provided to our customers is initially deferred and is recognized when the installation is completed and, in case of service contracts, over the life of those contracts. Revenue from extended and enhanced warranties is recognized in income on a straight-line basis over the contract period. The costs of providing services under extended and enhanced warranties are recognized when they occur.

ASML — Reconciliation U.S. GAAP — IFRS^1,4

Net income	Three months ended,
(in thousands EUR)	Apr 1, 2007			Mar 30, 2008
Net income under U.S. GAAP		152,675			145,123
Share-based payments (see Note 1)		122			(762	)
Capitalization of development costs (see Note 2)		22,682			21,681
Convertible subordinated notes (see Note 3)		(2,176	)		—
Income taxes (see Note 4)		(7,648	)		418
Net income under IFRS		165,655			166,460

Shareholders’ equity

	Apr 1,		Jul 1,		Sep 30,		Dec 31,		Mar 30,
(in thousands EUR)	2007		2007		2007		2007		2008
Shareholders’ equity under U.S. GAAP		2,147,730		2,317,997		1,831,433		1,890,943		1,958,154
Share-based payments (see Note 1)		523		3,924		7,126		787		(3,420	)
Capitalization of development costs (see Note 2)		113,451		110,749		120,344		138,424		157,900
Convertible subordinated notes (see Note 3)		29,239		27,019		2,894		—		—
Income taxes (see Note 4)		—		—		—		8,852		9,186
Shareholders’ equity under IFRS		2,290,943		2,459,689		1,961,797		2,039,006		2,121,820

Notes to the reconciliation from U.S. GAAP to IFRS

Note 1 Share-based Payments

Under IFRS, ASML applies IFRS 2, “Share-based Payments” beginning from January 1, 2004. In accordance with IFRS 2, ASML records as an expense the fair value of its share-based payments with respect to stock options granted to its employees after November 7, 2002.

Under U.S. GAAP, until December 31, 2005, ASML accounted for stock option plans using the intrinsic value method in accordance with APB 25 “Accounting for stock issued to employees” and provided pro forma disclosure of the impact of the fair value method on net income and earnings per share in accordance with SFAS No. 123 “Accounting for Stock Based Compensation”. As of January 1, 2006, ASML applies SFAS No. 123(R) “Share-Based Payment” which is a revision of SFAS No.123. SFAS 123(R) requires companies to recognize the cost of employee services received in exchange for awards of equity instruments based upon the grant-date fair value of those instruments.

Note 2 Capitalization of development costs

Under IFRS, ASML applies IAS 38, “Intangible Assets”. During the second half of 2004, ASML made changes to its administrative systems in order to provide sufficient information to comply with IFRS beginning from January 1, 2005. Sufficient reliable information to account for capitalization of development expenditures under IFRS before January 1, 2005 is not available. Under IAS 38, capitalized development expenditures are amortized over the expected useful life of the related product generally ranging between 2 and 3 years. Amortization starts when the developed product is ready for volume production.

Under U.S. GAAP, ASML applies SFAS No. 2, “Accounting for Research and Development Costs”. In accordance with SFAS No. 2, ASML charges costs relating to research and development to operating expense as incurred.

Note 3 Convertible Subordinated Notes

Under IFRS, ASML applies IAS 32 “Financial instruments: Disclosure and presentation” and IAS 39 “Financial instruments: Recognition and measurement” beginning from January 1, 2005. In accordance with IAS 32 and IAS 39, ASML accounts separately for the equity and liability component of its convertible notes (“Split accounting”). The equity component relates to the grant of a conversion option to shares to the holder of the bond. Split accounting results in additional interest charges.

Under U.S. GAAP, ASML accounts for its convertible bonds as a liability at the principal amount outstanding. As of December 31, 2007 ASML has no Convertible Subordinated Notes outstanding.

Note 4 Income taxes

Under IFRS, ASML applies IAS 12, “Income Taxes” beginning from January 1, 2005. In accordance with IAS 12, unrealized net income resulting from intercompany transactions that is eliminated from the carrying amount of assets on consolidation gives rise to a temporary difference for which deferred taxes must be recognized on consolidation. The deferred taxes are calculated based on the tax rate applicable in the purchaser’s tax jurisdiction.

Under U.S. GAAP, the elimination of unrealized net income from intercompany transactions that are eliminated from the carrying amount of assets on consolidation, give rise to a temporary difference for which prepaid taxes must be recognized on consolidation. Contrary to IFRS, the prepaid taxes under U.S. GAAP are calculated based on the tax rate applicable in the seller’s tax jurisdiction.

“Safe Harbor” Statement under the US Private Securities Litigation Reform Act of 1995: the matters discussed in this document may include forward-looking statements, including statements made about our outlook, realization of backlog, IC unit demand, financial results, average sales price, gross margin and expenses. These forward looking statements are subject to risks and uncertainties including, but not limited to: economic conditions, product demand and semiconductor equipment industry capacity, worldwide demand and manufacturing capacity utilization for semiconductors (the principal product of our customer base), competitive products and pricing, manufacturing efficiencies, new product development and customer acceptance of new products, ability to enforce patents and protect intellectual property rights, the outcome of intellectual property litigation, availability of raw materials and critical manufacturing equipment, trade environment, changes in exchange rates and other risks indicated in the risk factors included in ASML’s Annual Report on Form 20-F and other filings with the US Securities and Exchange Commission.

1	All quarterly information in this press release is unaudited.
2	The calculation of diluted net income per ordinary share assumes conversion of our Subordinated Notes as such conversions would have a dilutive effect.
3	The calculation of diluted net income per ordinary share assumes the exercise of options issued under ASML stock option plans as such exercises would have a dilutive effect.
4	As of January 1, 2008 ASML accounts for award credits offered to its customers as part of a volume purchase agreement using the deferred revenue model. Until December 31, 2007 the cost accrual method was used. This change in accounting policy was made because the deferred revenue model better reflects the business rationale. In addition the International Financial Reporting Interpretation Committee concludes in interpretation 13 (IFRIC 13 “Customer Loyalty Programmes”) that the deferred revenue model is the appropriate accounting treatment. Comparative figures for 2007 were adjusted to reflect this change in accounting policy. The impact of this change on equity as per January 1, 2007 amounted to EUR 8.1 million (decrease) and on net income for the year 2007 and the first quarter of 2008 amounted to EUR 8.6 million (decrease) and EUR 0.1 million (increase) respectively.